FDA Inspection 716890 — Boiron Inc.

Boiron Inc. — FEI 2510831

The FDA completed an inspection of Boiron Inc. on Mar 18, 2011 in Newtown Square, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newtown Square, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.